TABLE 1.
Isolate type and mutant or strain | EUCAST MIC (mg/liter) (susceptibility classification) forb: |
Etest MIC (mg/liter) (susceptibility classification) forc: |
|||||
---|---|---|---|---|---|---|---|
ANI | MICA | VOR | ISA | FLU | CAS | AMB | |
Clinical isolates or QCd strain | |||||||
SCL 1130.04e | <0.008 (S) | <0.008 (S) | 0.5 (R) | 0.06 | >16 (R) | 0.125 (S) | 0.5 (S) |
RRCL 110.1f | 0.03 (S) | >1 (R) | 4 (R) | 0.5 | >16 (R) | 2 (R) | 0.5 (S) |
ATCC 22019g | 0.125 (I) | >1 (I) | <0.03 (S) | <0.03 | 2 (S) | 0.5 (S) | 0.38 (S) |
Mutant isolates or QC strain | |||||||
SSWT SC5314h | 0.015 (S) | <0.008 (S) | <0.03 (S) | <0.03 | 0.25 (S) | 0.19 (S) | 0.25 (S) |
RRMH2h | 0.06 (R) | 0.03 (R)i | <0.03 (S) | <0.03 | 0.25 (S) | 0.75 (R) | 0.19 (S) |
RSMH1h | 0.015 (S) | 0.03 (R)j | <0.03 (S) | <0.03 | <0.125 (S) | 0.25 (S) | 0.25 (S) |
SRMH1h | 0.015 (S) | 0.008 (S) | <0.03 (S) | <0.03 | 0.25 (S) | 0.25 (S) | 0.25 (S) |
RRMHO2h | 0.06 (R) | 1 (R)k | <0.03 (S) | <0.03 | <0.125 (S) | 1 (R) | 0.38 (S) |
ATCC 6258g | 0.06 (S) | 0.125 | 0.125 (S) | <0.03 | 16 (R) | 0.38 (I) | 0.75 (S) |
Susceptibility classifications were performed according to the EUCAST breakpoints (BP), except for CAS and Etest, for which CLSI BP were adopted, as recommended by the manufacturer.
ANI, anidulafungin; MICA, micafungin; VOR, voriconazole; ISA, isavuconazole; FLU, fluconazole; S, susceptible; R, resistant; I, intermediate.
CAS, caspofungin; AMB, amphotericin B.
QC, quality control.
The clinical isolates 952.04 and 5104.04 revealed the same MICs within ±1 dilution step difference; these strains do not carry coding FKS1 HS1 or HS2 mutations.
The clinical isolate 111.12 revealed the same MIC within ±1 dilution step difference; these strains carry the mutations R647R/G and P649P/L.
Quality-control strains.
SC5314 is the wild-type parental strain; mutations carried by the strains are as follows: RRMH2, R647R/G and P649P/L; RSMH1, R647R/G; SRMH1, P649P/L; and RRMHO2, R647G and P649L.
Micafungin trailing 0.03 to 1 but stays at <50% endpoint in this range.
Micafungin creeping increase 0.03 to 0.25.
Micafungin trailing 0.06 to 0.25 and just >50% endpoint in this range.